Bio Dr. Dileep R. Yavagal, MD, FAHA, FAAN, FSVIN is the Director of Interventional Neurology and Co-Director of Neuroendovascular Surgery at the University of Miami & Jackson Memorial Hospitals and Clinical Professor of Neurology and Neurosurgery at the University of Miami of Medicine. He is the founder and Global Co-Chair of the Mission Thrombectomy 2020+ Campaign. Dr. Yavagal is an international thought leader in endovascular therapy for ischemic and hemorrhagic stroke as well as a pioneer in the translation of intra-arterial delivery of cell therapy for stroke. He was the national Co-PI of the first US multicenter clinical trial of Intraarterial delivery of autologous bone marrow stem cells for ischemic stroke: RECOVER Stroke. Dr. Yavagal has received several state and federal research grants to study endovascular stemcell therapies for ischemic stroke using small and large animal models of stroke in his researchlaboratory. He is considered a pioneering researcher the field of intra-arterial delivery of stemcells in stroke therapy. In 2018, he appointed to lead the Neurological Cell Therapy Platform at the Interdisciplinary Stem Cell Institute at the University. Dr. Yavagal has also made significant contributions in the field of mechanical thrombectomy for stroke. He was on the on the steering committee of the SWIFT-Prime and MR RESCUE, both landmark randomized clinical trials of endovascular stroke therapy. He co-authored the landmark 2015 AHA Endovascular Stroke Therapy Guidelines as well asthe recent groundbreaking DAWN stroke trial in the New England Journal of Medicine. He has also co-authored the AHA Policy statement on Stroke Systems of Care published in May 2019 He is the founder and Past-President of the Society for Vascular and Interventional Neurology (SVIN).